Rate My Professor Adam Walker

Walker's research utilizes biochemistry, imaging techniques, neuronal cell cultures, genetically modified mouse models, and human brain and spinal cord tissues to investigate TDP-43 proteinopathies in motor neuron disease (amyotrophic lateral sclerosis) and frontotemporal dementia. His group characterized the rNLS8 TDP-43 mouse model, demonstrating early cytoplasmic TDP-43 accumulation, activation of stress pathways, synaptic changes, microglial responses, glymphatic dysfunction, and progressive motor deficits. These models serve as platforms for dissecting disease mechanisms and testing preclinical therapeutics. His laboratory has received funding from the NHMRC, Australian National Foundation for Medical Research and Innovation, Dementia Australia, Motor Neuron Disease Research Institute of Australia, MonSTaR Foundation, and Cure for MND Foundation for projects on TDP-43 clearance, complement modulators, and protein homeostasis. Key publications include San Gil et al. (2024) 'A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration' in Nature Communications; Luan et al. (2023) 'Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD' in Molecular Psychiatry; and Bademosi and Walker (2022) 'Cryptic inclusions UNCover losses driving neurodegeneration' in Trends in Genetics. Walker's contributions have provided critical tools and insights advancing therapeutic strategies in neurodegenerative diseases.